Cargando…

Successful Hemostasis with Extended Half-life Recombinant Factor VIII in Circumcision

Detalles Bibliográficos
Autores principales:	Koç, Başak, Öztürk, Metin İshak, Zülfikar, Bülent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057741/ https://www.ncbi.nlm.nih.gov/pubmed/31833714 http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0305

Ejemplares similares

Comparison of extended to standard half-life recombinant factor VIII therapy in patients with hemophilia A on prophylactic therapy
por: McCall, Michael, et al.
Publicado: (2019)

Clinical problems and surgical interventions in inherited factor VII deficiency
por: Şenol, Başak Koç, et al.
Publicado: (2020)

Persons With Hemophilia of Generation Y and Their Relatives Attitudes and Expectations From Treatment
por: Zulfikar, Bulent, et al.
Publicado: (2021)

Comparison of Real-World Dose and Consumption for Two Extended Half-Life Recombinant Factor VIII Products for the Treatment of Hemophilia A in the United States
por: Wu, Yanyu, et al.
Publicado: (2022)

Plastibell Circumcision
por: Yasri, Sora, et al.
Publicado: (2018)

Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products
por: Teitel, Jerome, et al.
Publicado: (2021)

Case report: successful perioperative management of patients with haemophilia A using an extended half-life factor VIII (Efmoroctocog alfa) during neurosurgical procedures
por: Kocher, Florian, et al.
Publicado: (2021)

Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A
por: Coyle, T E, et al.
Publicado: (2014)

Hypovolemic Shock after Circumcision
por: Sarsu, Sevgi Buyukbese, et al.
Publicado: (2014)

Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples
por: Augustsson, Cecilia, et al.
Publicado: (2020)

Circumcision in Girls
Publicado: (1912)

Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective
por: Lorenzoni, Valentina, et al.
Publicado: (2018)

Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach
por: Solms, Alexander, et al.
Publicado: (2019)

Aposthia-A Motive of Circumcision Origin
por: Amin ud din, M
Publicado: (2012)

Penile Skin Bridges after Circumcision
por: Kampouroglou, Georgios, et al.
Publicado: (2015)

Surgical outcomes in patients with haemophilia A or B receiving extended half‐life recombinant factor VIII and IX Fc fusion proteins: Real‐world experience in the Nordic countries
por: Lehtinen, Anna‐Elina, et al.
Publicado: (2022)

Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?
por: Allard, Quentin, et al.
Publicado: (2020)

A new recombinant factor VIII: from genetics to clinical use
por: Kannicht, Christoph, et al.
Publicado: (2015)

Use of collagen in post-circumcision raw area of glans
por: Saraiya, Hemant A.
Publicado: (2012)

Male circumcision is not associated with an increased prevalence of erectile dysfunction
por: Wolff, Ingmar, et al.
Publicado: (2014)

Circumcision: Viable treatment option for resistant genital warts
por: Neema, Shekhar, et al.
Publicado: (2016)

Glenzocimab does not impact glycoprotein VI-dependent inflammatory hemostasis
por: Jadoui, Soumaya, et al.
Publicado: (2020)

Half-and-half nail in a case of isoniazid-induced pellagra
por: Ma, Yiping, et al.
Publicado: (2014)

Half and half blisters in pemphigus vulgaris: A diagnostic quandary
por: Rather, Shagufta, et al.
Publicado: (2016)

Postpartum Acquired Hemophilia Factor VIII Inhibitors and Response to Therapy
por: Karakuş, Volkan, et al.
Publicado: (2012)

Recombinant factor VIIa and factor VIII treatment for acquired factor VIII deficiency: a case of repeated thrombotic endotracheal occlusion in a mechanically ventilated patient
por: Lauer, Stefan, et al.
Publicado: (2011)

Half-Way Houses
por: Koll, L. M.
Publicado: (1953)

Commentary on “Disposable circumcision suture device: clinical effect and patient satisfaction”
por: Cao, De-Hong, et al.
Publicado: (2015)

Performance Evaluation of the Preanalytic Module of the ACL TOP 750 Hemostasis Lab System
por: Kwoun, Woo-Jae, et al.
Publicado: (2018)

The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis
por: Wada, Hideo, et al.
Publicado: (2017)

Endoscopic Hemostasis of a Bleeding Diverticular Dieulafoy's Lesion in the Third Portion of Duodenum
por: Anam, Hameed, et al.
Publicado: (2022)

Evaluation of Unfavorable Cardiovascular and Metabolic Risk Factors in Children and Young Adults with Haemophilia
por: Yıldız, Melek, et al.
Publicado: (2019)

Perioperative haemostasis with full‐length, PEGylated, recombinant factor VIII with extended half‐life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single‐arm phase III trial
por: Gruppo, Ralph, et al.
Publicado: (2019)

No half-time for COVID-19
por: Lin, I-Cheng, et al.
Publicado: (2022)

Chimeric antibodies with extended half-life in ferrets
por: Nesspor, Thomas C, et al.
Publicado: (2014)

ENDOSCOPIC HEMOSTASIS OF A BLEEDING GASTRIC GASTROINTESTINAL STROMAL TUMOR (GIST) WITH ENDOLOOP PLACEMENT
por: RETES, Felipe Alves, et al.
Publicado: (2015)

Commentary on “Risk Factors for Transurethral Coagulation for Hemostasis During Holmium Laser Enucleation of the Prostate”
por: Maheshwari, Pankaj N., et al.
Publicado: (2022)

White-light-induced synthesis of injectable alginate-based composite hydrogels for rapid hemostasis
por: Zhang, Meng-De, et al.
Publicado: (2023)

Commentary on “Countries with high circumcision prevalence have lower prostate cancer mortality”
por: Kupferschmid, Christoph
Publicado: (2016)

Assessing the Performance of Extended Half-Life Coagulation Factor VIII, FC Fusion Protein by Using Chromogenic and One-Stage Assays in Saudi Hemophilia A Patients
por: Owaidah, Tarek M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sosj3qlkvp9361fefhm8bpuh49